-
Challenges Facing the South African Pharmaceutical Industry
I am a firm and unapologetic believer that the partnership of NGOs, national and international health governance with the pharmaceutical industry, rather than its exclusion, is vital to the effective treatment of disease globally. Read more
-
On Booze, Babies and Birth defects:
A brief commentary on Foetal Alcohol Spectrum Disorders _____________________________________________________ Foetal Alcohol Spectrum Disorders (FASDs) are a group of disorders of global concern. Entirely attributed to prenatal alcohol exposure, affected individuals suffer a lifetime of physical, psychological and social consequences. Foetal Alcohol Syndrome (FAS), has a global prevalence of 2.89 per 1000 live births, with some… Read more
-
Seven lessons I learned from Professor Hans Rosling: A Tribute
Last week we lost one of the greatest statisticians of our time. A clinician who informed scholars and audiences world over; and a researcher whose work on economic development and global health changed the way we view our world. Personally, too, I have lost a role model, Dr Hans Rosling of the Karolinska Institute. Nonetheless,… Read more
-
Hans Rosling: A Tribute
He was a clinician and statistician whose research and accessible insights changed the way we view the world, and our understandings of the complex relationships between development and health. Read more
-
Rethinking Rabies: A Breakthrough in Management? – My comments on the literature
Rabies is a vaccine-preventable, zoonotic disease of global concern, resulting in over 55 000 deaths annually. Whilst standard post-exposure treatments are estimated to prevent hundreds of thousands of fatalities, these are not without shortcomings. Recent immunological research into novel treatments has revealed promising results. Published in the Journal of Infectious Diseases, the research paper this… Read more
-
Coming soon: Rethinking Rabies. A Breakthrough in Management?
Rabies is a vaccine-preventable, zoonotic disease of global concern, resulting in over 55 000 deaths annually. Whilst standard post-exposure treatments are estimated to prevent hundreds of thousands of fatalities, these are not without shortcomings. Recent immunological research into novel treatments has revealed promising results. More on this later this week. For now, have a stellar… Read more
Recent Posts
- Global Health Conversations Podcast Launches April 2023
- What are Clinical Trials ?
- My first internship at the World Health Organisation – A formative experience and an education in the value of community-based medicine
- Human Rights Council – 40th Regular Session
- Life Cycle Management: An ‘Insider’s’ guide on how to make your drug last FOREVER $$$